Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease

Cited by (373)

Items 201–300 of 373

1. ECHS1-NOX4 interaction suppresses rotenone-induced dopaminergic neurotoxicity through inhibition of mitochondrial ROS production
   Zirui Zhao, Ruonan Wang, Haitao Ge, Liyan Hou, Taku Hatano, Nobutaka Hattori, Hong Su, Qingshan Wang, Jie Zhao · 2025 · Free Radical Biology and Medicine
2. Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
   Yeseong Choi, Won‐Suk Chung · 2025 · Molecular Neurodegeneration
3. The Synucleins and the Astrocyte
   Abigail J. Myers, Ayat Brahimi, Imani J. Jenkins, Andrew O. Koob · 2023 · Biology
4. Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders
   Alexandra Benchoua, Marie Lasbareilles, Johana Tournois · 2021 · Cells
5. Dysregulation of protein degradation and alteration of secretome in α-synuclein-exposed astrocytes: implications for dopaminergic neuronal dysfunction
   Aishwarya Raj, Roon Banerjee, Vikram Venkappayya Holla, Nitish L. Kamble, Ravi Yadav, Pramod Kumar Pal, Indrani Datta · 2024 · Cell Communication and Signaling
6. Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration
   Hélèna L. Denis, Aurélie de Rus Jacquet, Melanie Alpaugh, Michel Panisset, Roger A. Barker, Éric Boilard, Francesca Cicchetti · 2025 · Fluids and Barriers of the CNS
7. Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
   Xiangge Guo, Xumeng Wang, Jiaxuan Wang, Min Ma, Qian Ren · 2025 · International Journal of Molecular Sciences
8. Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson’s disease
   Paulina Gątarek, Joanna Kałużna‐Czaplińska · 2024 · Expert Review of Proteomics
9. The mechanisms of white matter injury and immune system crosstalk in promoting the progression of Parkinson’s disease: a narrative review
   Wen Ma, Yifan Geng, Youhan Liu, Huixin Pan, Qinglu Wang, Yaohua Zhang, Liping Wang · 2024 · Frontiers in Aging Neuroscience
10. The PINK1-Mediated Crosstalk between Neural Cells and the Underlying Link to Parkinson’s Disease
    Elvira P. Leites, Vanessa A. Morais · 2021 · Cells
11. In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders
    Dalinda Isabel Sánchez-Vidaña, Jingjing Li, Samuel Abokyi, Jackie Ngai-Man Chan, Shirley P.C. Ngai, Benson Wui-Man Lau · 2023 · Frontiers in Molecular Neuroscience
12. Immunosenescence: Molecular Mechanisms, Diseases, and Therapeutic Innovations
    Ninghan Gong, Xiting Pan, Yusi Deng, Jiajia Che, Junhao Bao, Mengqi Wang, Chuan Xu, Xiaowei Liu, Ying Shi · 2025 · MedComm
13. Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?
    Julia Sala‐Jarque, Karolina Zimkowska, Jesús Ávila, Isidró Ferrer, José Antonio del Río · 2022 · International Journal of Molecular Sciences
14. Neural lineage differentiation of human pluripotent stem cells: Advances in disease modeling
    Yuan-Wei Yan, Eddie S. Qian, Lauren Elizabeth Woodard, Julie Bejoy · 2023 · World Journal of Stem Cells
15. Astrocytic proteostasis in the tale of aging and neurodegeneration
    Felipe Cabral‐Miranda, Isadora C. Pereira Matias, Flávia Carvalho Alcântara Gomes · 2024 · Ageing Research Reviews
16. Aging, Parkinson’s Disease, and Models: What Are the Challenges?
    Ilaria Bellantuono, Heather Mortiboys, Emily M. Rocha, Manish Chamoli, Shankar J. Chinta, Julie Kay Andersen, Ruby Wallis, Erwan Bézard, Matt Goldberg, Tim Greenamyre et al. · 2023
17. Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms
    Agustín Cota-Coronado, Jennifer C. Durnall, Néstor Fabián Díaz, Lachlan H. Thompson, N.E. Díaz-Martínez · 2020 · Molecules
18. Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years
    Alice Filippini, Massimo Gennarelli, Isabella Russo · 2021 · Biochemical Society Transactions
19. Human Stem Cell-derived Aggregates of Forebrain Astroglia Respond to Amyloid Beta Oligomers
    Kyle Griffin, Julie Bejoy, Liqing Song, Timothy Hua, Mark Marzano, Richard Jeske, Qing‐Xiang Amy Sang, Yan Li · 2019 · Tissue Engineering Part A
20. Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain
    Benjamin Guy Trist, Courtney Jade Wright, Alejandra Rangel, Louise Cottle, Asheeta Prasad, Nanna Møller Jensen, Hjalte Gram, Nicolas L. Dzamko, Poul Henning Jensen, Deniz Kirik · 2024 · npj Parkinson s Disease
21. Neurodegenerative brain models vs. cell replacement or restoration therapy: A review on promises and pitfalls
    Dhiraj Kumar, Md. Imtaiyaz Hassan · 2021 · Biochemical and Biophysical Research Communications
22. Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models
    Julie Bigarreau, Nathalie Rouach, Anselme L. Perrier, Franck Mouthon, Mathieu Charvériat · 2022 · International Journal of Molecular Sciences
23. Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders
    Aishika Datta, Deepaneeta Sarmah, Harpreet Kaur, Antra Chaudhary, Namrata Vadak, Anupom Borah, Sudhir V. Shah, Xin Wang, Pallab Bhattacharya · 2022 · Cellular and Molecular Neurobiology
24. Chaperone-Mediated Autophagy in Pericytes: A Key Target for the Development of New Treatments against Glioblastoma Progression
    María Dolores Salinas, Rut Valdor · 2022 · International Journal of Molecular Sciences
25. Reduced Bergmann glial process terminations and lateral appendages in essential tremor
    David S. Ruff, Ilaria Balbo, Ruo‐Yah Lai, Diarra Dieng, Charlotte Hennessey, Krish Vennam, Andrew J. Dwork, Morgan McCreary, Elan D. Louis, Phyllis L. Faust et al. · 2023 · Annals of Clinical and Translational Neurology
26. New perspectives on heterogeneity in astrocyte reactivity in neuroinflammation
    Daniel Evangelista Santos, Sarah Alexandra Silva Lima, Leticia Santos Moreira, Sílvia Lima Costa, Clarissa Schitine · 2025 · Brain Behavior & Immunity - Health
27. α-Synuclein aggregates induce mitochondrial damage and trigger innate immunity to drive neuron–microglia communication
    Ranabir Chakraborty, Stephanie Maya, Veronica Testa, Jara Montero-Muñoz, Takashi Nonaka, Masato Hasegawa, Antonella Consiglio, Chiara Zurzolo · 2026 · Nature Communications
28. Role of Astrogliosis in the Pathogenesis of Parkinson’s Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target
    Bharat Bhushan, Niraj Kumar Singh · 2023 · CNS & Neurological Disorders - Drug Targets
29. LRRK2 G2019S and Parkinson’s disease: insight from Neuroinflammation
    Xiao-Yan Yao, Li-Na Guan, Qi Chen, Chao Ren · 2023 · Postgraduate Medical Journal
30. Current potential biomarkers for Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis: review of literature
    Jiaman Peng, Ting Fan, Junling Wang, Youqing Deng, Renshi Xu · 2026 · Dialogues in Clinical Neuroscience
31. Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
    Lim, Dmitry, Matute, Carlos, Cavaliere, Fabio, Verkhratsky, Alexei · 2025 · Handbook of Clinical Neurology
32. From in vitro to in vivo reprogramming for neural transdifferentiation: An approach for CNS tissue remodeling using stem cell technology
    Naohiro Egawa, Hidefumi Suzuki, Ryōsuke Takahashi, Kazuhide Hayakawa, Wenlu Li, Eng H. Lo, Ken Arai, Haruhisa Inoue · 2020 · Journal of Cerebral Blood Flow & Metabolism
33. Targeting chaperone-mediated autophagy for Parkinson’s disease therapy
    Jiahong Lu, Yi-Ting Wang · 2022 · Neural Regeneration Research
34. The Use of Human Induced Pluripotent Stem Cells for Testing Neuroprotective Activity of Pharmacological Compounds
    Ekaterina V. Novosadova, Elena L. Arsenyeva, Stanislav A. Antonov, Yulia Vanyushina, Tatyana Malova, Alexey A. Komissarov, Sergey Nikolaevich Illarioshkin, Л. Г. Хаспеков, Л. А. Андреева, Nikolai F. Myasoedov et al. · 2019 · Biochemistry (Moscow)
35. Sources of Oxidative Stress in Parkinson’s Disease: Pathways and Therapeutic Implications
    Yordan Yordanov, Denitsa Stefanova, Magdalena Kondeva-Burdina, Virginia Tzankova · 2026 · Antioxidants
36. Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson’s Disease
    Jennifer Sally Samson, Anuradha Ramesh, Venkatachalam Deepa Parvathi · 2024 · Neuroscience
37. Role of connectivity anisotropies in the dynamics of cultured neuronal networks
    Akke Mats Houben, Jordi García‐Ojalvo, Jordi Soriano · 2025 · PLoS Computational Biology
38. The Role of Human LRRK2 in Methylmercury-Induced Inhibition of Microvesicle Formation of Cephalic Neurons in Caenorhabditis elegans
    Tao Ke, Abel Santamarı́a, João Batista Teixeira da Rocha, Alexey A. Tinkov, Rongzhu Lu, Aaron B. Bowman, Michael Aschner · 2020 · Neurotoxicity Research
39. CD49f is a novel marker to purify functional human iPSC-derived astrocytes
    Lilianne Barbar, Tanya Jain, Matthew Zimmer, Ilya Kruglikov, Suzanne R. Burstein, Tomasz Rusielewicz, Madhura P. Nijsure, Gist F. Croft, Minghui Wang, Bin Zhang et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
40. IPSC-derived midbrain astrocytes from Parkinson’s disease patients carrying pathogenic SNCA mutations exhibit alpha-synuclein aggregation, mitochondrial fragmentation and excess calcium release
    Peter A. Barbuti, Paul M. A. Antony, Gabriella Novak, Simone B. Larsen, Clara Berenguer-Escuder, Bruno F. R. Santos, François Massart, Dajana Großmann, Takahiro Shiga, Kei‐ichi Ishikawa et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
41. Impaired $$\alpha$$-Synuclein aggregate clearance in neuronal cells drive their spread to microglia through tunneling nanotubes
    Ranabir Chakraborty, Francesca Palese, Philippa Samella, Veronica Testa, Jara Montero-Muñoz, Sylvie Syan, Takashi Nonaka, Masato Hasegawa, Antonella Consiglio, Chiara Zurzolo · 2026 · Nature Communications
42. Astrocytes initiate autophagic flux and maintain cell viability after internalizing non-active native extracellular α-synuclein
    Fotis Andromidas, Brooke MacKinnon, Abigail J. Myers, Melanie M. Shaffer, Ayat Brahimi, Saeid Atashpanjeh, Tiana L. Vazquez, Timmy Le, Evan R. Jellison, Susan Staurovsky et al. · 2024 · Molecular and Cellular Neuroscience
43. Connexin 43 is downregulated in advanced Parkinson’s disease in multiple brain regions which correlates with symptoms
    Nataly Hastings, S.M. Jamshedur Rahman, Przemysław Stempor, Matthew Thomas Wayland, Wei‐Li Kuan, Mark Kotter · 2025 · Scientific Reports
44. Role of Chaperone-Mediated Autophagy in Ageing Biology and Rejuvenation of Stem Cells
    Emanuela Vitale, Sadia Perveen, Daniela Rossin, Marco Lo Iacono, Raffaella Rastaldo, Claudia Giachino · 2022 · Frontiers in Cell and Developmental Biology
45. LRP10 and α-synuclein transmission in Lewy body diseases
    Ana Carreras Mascaro, Martyna M. Grochowska, Valerie Boumeester, Natasja F. J. Dits, Ece Naz Bilgiҫ, Guido J. Breedveld, Leonie J.M. Vergouw, Frank Jan de Jong, Martin E. van Royen, Vincenzo Bonifati et al. · 2024 · Cellular and Molecular Life Sciences
46. Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils
    Alice Filippini, Giulia Carini, Alessandro Barbon, Massimo Gennarelli, Isabella Russo · 2025 · Acta Neuropathologica Communications
47. Integrated profiling of single cell epigenomic and transcriptomic landscape of Parkinson’s disease mouse brain
    Jixing Zhong, Gen Tang, Jiacheng Zhu, Xin Qiu, Weiying Wu, Ge Li, Xiumei Lin, Langchao Liang, Chaochao Chai, Yuying Zeng et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
48. Neuronal Autophagy Failure Drives α-Synuclein Transfer to Microglia to Outsource Aggregate Clearance
    Ranabir Chakraborty, Philippa Samella, Veronica Testa, Jara Montero-Muñoz, Takashi Nonaka, Masato Hasegawa, Antonella Consiglio, Chiara Zurzolo · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
49. Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson’s disease iPSC model
    Christina Paschou, Olympia Apokotou, Konstantina Charmpi, Anastasios Kollias, Sofia Dede, Martina K. Samiotaki, Paraskevi N. Koutsoudaki, Sophia Havaki, Francesca Palese, Konstantina Dimoula et al. · 2025 · Proceedings of the National Academy of Sciences
50. Interplay between lipid droplets and alpha-synuclein: implication in Parkinson’s disease pathogenesis
    Walid Idi, Razan Sheta, Abid Oueslati · 2025 · Frontiers in Molecular Neuroscience
51. Astrocytic lysosome deficits reduce alpha-synuclein degradation and induce the spread of pathology
    Lindsay M. Roth, Olga Morozova, Jan Stöhr, Jason Schapansky · 2026 · Neurobiology of Disease
52. Polyethyleneimine facilitates the growth and electrophysiological characterization of iPSC-derived motor neurons
    Meimei Yang, Daofeng You, Gang Liu, Yin Lu, Guangming Yang, Timothy O’Brien, David Clifford Henshall, Orla M. Hardiman, Cai Li, Min Liu et al. · 2024 · Scientific Reports
53. LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses
    Tuuli-Maria Sonninen, Sanni Peltonen, Jonna Niskanen, Riikka H. Hämäläinen, Jari Koıstınaho, Šárka Lehtonen · 2024 · International Journal of Molecular Sciences
54. Progression of differentiation of iPSCs into specific subtypes of neurons
    Jingwen Wang, Ruijie Ji, Lei Zhang, Xiang Cheng, Xinhua Zhang · 2025 · Differentiation
55. Fountain of youth—Targeting autophagy in aging
    Lea Danics, Anna Anoir Abbas, Balázs Kis, Karolina Pircs · 2023 · Frontiers in Aging Neuroscience
56. Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite
    Huabin Hu, Carmen Serra, Wenjie Zhang, Aurora Scrivo, Irene Fernández‐Carasa, Antonella Consiglio, Àlvaro Aytés, Miguel Ángel Pujana, Amadeu Llebaria, Albert A. Antolín · 2024 · Cell chemical biology
57. Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells
    Erin Knock, Lisa M. Julian · 2021 · Frontiers in Cellular Neuroscience
58. Astrocytes réactifs et maladies cérébrales
    Yiannis Poulot-Becq-Giraudon, María-Angeles Carrillo-de Sauvage, Carole Escartin · 2022 · médecine/sciences
59. CRISPR: a tool with potential for genomic reprogramming in neurological disorders
    Yogesh Kumar Dhuriya, Aijaz Ahmad Naik · 2022 · Molecular Biology Reports
60. Differentiation of astrocytes with characteristics of ventral midbrain from human embryonic stem cells
    Gyu‐Bum Yeon, Byeong‐Min Jeon, Seo Hyun Yoo, Dongyun Kim, Seung Soo Oh, Sanghyun Park, Won-Ho Shin, Hyung Wook Kim, Dokyun Na, Dae‐Sung Kim et al. · 2023 · Stem Cell Reviews and Reports
61. CAV-2-Mediated GFP and LRRK2G2019S Expression in the Macaca fascicularis Brain
    Carla DiCaudo, Iván Martínez-Valbuena, Iñaki-Carril Mundiñano, Aurélie Gennetier, María Hernández, Mar Carmona‐Abellán, Irene Marcilla, Eric J. Kremer, M. R. Luquín · 2020 · Frontiers in Molecular Neuroscience
62. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    KR Bowles, DA Pugh, Y Liu, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, P Heutink, A Siitonen, S Bertelsen, Jonathan D. Cherry et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
63. Downregulating α-synuclein in iPSC-derived dopaminergic neurons mimics electrophysiological phenotype of the A53T mutation
    Philipp Hornauer, Gustavo Prack, Nadia Anastasi, Silvia Ronchi, Taehoon Kim, Christian Donner, Fiscella Michele, Karsten Michael Borgwardt, Verdon Taylor, Ravi Jagasia et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
64. Targeting of CH25H to boost p62-dependent autophagic degradation of α-synuclein in cell and mouse models of Parkinson’s disease
    Xiwei Zhang, Ruixue Han, Wei Zhang, Shenhan Xu, Yueping Wang, Min Wang, Ren‐Hong Du, Yang Liu, Li Zhang, Cong Wang et al. · 2026 · Science Translational Medicine
65. Unleashing the Power of Induced Pluripotent stem Cells in in vitro Modelling of Lesch-Nyhan Disease
    Sundas Javed, Marco Fersini, Giulia Bernardini · 2024 · Stem Cell Reviews and Reports
66. Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration
    Santiago Rodríguez-Carreiro, Maria del Carmen Nogales, David Jiménez-Galán, Sara Carmona-Lorenzo, Alicia Caro-Martín, Elisa Navarro, Noemí Esteras · 2024 · Regenerative medicine reports .
67. Neurogliovascular alterations in brain pathologies across lifespan
    Béatrice Daigle, Laura Menegatti Bevilacqua, Valérie Pineau Noël, Manon Lebel, Daniel C. Côté, LevesqueMartin Lévesque, Caroline Ménard · 2024 · Glial health research.
68. Parkinson’s disease LRRK2 mutations dysregulate iron homeostasis and promote oxidative stress and ferroptosis in human neurons and astrocytes
    Adamantios Mamais, Richard D. Batchelor, Chairmandurai Aravindraja, Thomas B. Ladd, Austin J. Shute, Nitya Subrahmanian, Nunziata Maio, Chris D. Vulpe, Matthew J. LaVoie · 2026 · Molecular Neurodegeneration
69. Generation and Characteristics of Glial Cells from Induced Human Pluripotent Stem Cells
    Ekaterina V. Novosadova, Е. Л. Арсеньева, Stanislav A. Antonov, Е. А. Казанцева, Lyudmila V. Novosadova, О. Д. Курко, Sergey Nikolaevich Illarioshkin, Vyacheslav Z. Tarantul, Igor A. Grivennikov · 2020 · Neurochemical Journal
70. Complexation design of cationized gelatin and molecular beacon to visualize intracellular mRNA
    Sho Takehana, Yuki Murata, Jun‐ichiro Jo, Yasuhiko Tabata · 2021 · PLoS ONE
71. CRISPR/Cas9 technology in neurological disorders: An update for clinicians
    Achal K Srivastava, Vishnu Swarup, Vikas Kumar, Mohammed Faruq, Himanshu Narayan Singh, Inder Singh · 2020 · Annals of Movement Disorders
72. Emerging autophagic endo-lysosomal targets in the management of Parkinson's disease
    T. Siddiqui, Lokesh Kumar Bhatt · 2023 · Revue Neurologique
73. Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment
    Zhiqi Yang, Mingyue Gong, Chuanyan Yang, Chunhai Chen, Kuan Zhang · 2023 · Handbook of experimental pharmacology
74. Preparation of astrocytes by directed differentiation of pluripotent stem cells and somatic cell transdifferentiation
    Hangjie Chen, Kang Zheng, Mengsheng S. Qiu, Junlin Yang · 2023 · Developmental Neurobiology
75. Chitosan-Based Biomaterials for Tissue Engineering of Glial Cells
    Youssef Ait Hamdan, Hassane Oudadesse, Jawad Laadraoui, Kamal Smimih, Hamid Kabdy, Samia Elouali, Nadia Eladlani, Mohammed Rhazi · 2023 · Advances in bioinformatics and biomedical engineering book series
76. DHM/SERS reveals cellular morphology and molecular changes during iPSCs-derived activation of astrocytes
    Xiaoya Bu, Liwei Yang, Xianxin Han, Shengde Liu, Xiaoxu Lü, Jianhui Wan, Xiao Zhang, Ping Tang, Weina Zhang, Liyun Zhong · 2024 · Biomedical Optics Express
77. The application of iPSCs in Parkinson’s disease
    Josefine Jul Jarbæk Nielsen, Thea Pinholt Lillethorup, Andreas Nørgaard Glud, Jens Christian Hedemann Sørensen, Dariusz Orłowski · 2020 · Acta Neurobiologiae Experimentalis
78. Parkinson's disease
    Juan Segura‐Aguilar · 2021 · Elsevier eBooks
79. Autophagy Impairment in Parkinson’s Disease: Approaches to Therapy
    Tatiana S. Usenko · 2025 · Molecular Biology
80. Generation of iPSC Lines with Tagged α-Synuclein for Visualization of Endogenous Protein in Human Cellular Models of Neurodegenerative Disorders
    Oskar G. Zetterdahl, James A Crowe, Samira Reyhani, Miriam A. Güra, Ot Labastida-Botey, Aline S. Girard, D. Sean Froese, Henrik Ahlenius, Isaac Canals · 2025 · eNeuro
81. Chaperone‐Mediated Autophagy: A Critical Regulator of Neuroinflammation and Neurodegeneration
    Yingying Han, Xinyue Huang, Ying Su, Jingjing Ma, Jin Wu · 2025 · Advanced Biology
82. Astrocyte Autophagy in Neurodegenerative Diseases: Current Progress in Mechanisms and Therapeutics
    Jialei Qian, Shengyuan Ren, Tianning Ren, Renke Shi, Liang Qiao, Jing‐Qiong Kang · 2025 · Neurochemical Research
83. Human pluripotent stem cell engineering with CRISPR–Cas9 for Parkinson’s disease
    Seung Bin Park, Jae‐Joong Kim, Yuri Ha, Min Seong Kim, Tae Wan Kim · 2026 · Experimental & Molecular Medicine
84. Using iPSC models to examine neuron–glia interactions in neurodegenerative diseases
    Dianne Marquez Lopez, Lois Keavey, Kathryn R. Bowles · 2026 · Bioscience Reports
85. The Dual Role of Glial Extracellular Vesicles in Neurodegeneration: Insights from iPSC-Based Models
    Aurora Scrivo, Liliana Inácio Bernardino, Antonella Consiglio · 2026 · International Journal of Molecular Sciences
86. Metabolic Plasticity of Astrocytes
    Yana V. Gorina, Alla B. Salmina, A. I. Erofeev, Zhao Can, Anastasia V. Bolshakova, Pavel M. Balaban, Безпрозванный Илья Борисович, О. Л. Власова · 2021 · Journal of Evolutionary Biochemistry and Physiology
87. An Introspective Approach: A Lifetime of Parkinson’s Disease Research and Not Much to Show for It Yet?
    Gordon William Arbuthnott · 2021 · Cells
88. Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells
    George E. Allen, Aaron S. Dhanda, Lisa M. Julian · 2022 · Methods in molecular biology
89. Altered autophagy on the path to Parkinson's disease
    Irene Sanchez-Mirasierra, Sergio Hernández-Díaz, Saurav Ghimire, Patrick Main, Sandra‐Fausia Soukup · 2021 · Elsevier eBooks
90. Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma
    Maria L Molina, David García‐Bernal, Salvador Martı́nez, Rut Valdor · 2020 · Vide Leaf, Hyderabad eBooks
91. Proteostasis dysregulation in p.A53T-α-Synuclein iPSC-derived astrocytes exacerbates neurodegeneration in a Parkinson’s disease model with Lewy-like pathology
    Christina Paschou, Olympia Apokotou, Αναστάσιος Κόλλιας, Konstantina Charmpi, Sofia Dede, Martina K. Samiotaki, Francesca Palese, Konstantina Dimoula, Evangelia Emmanouilidou, Era Taoufik et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
92. Parkinson's Disease Involving Glial Cell Dysfunction
    Mjid Oukhrib, Lahcen Tamegart, Hafida El Ghachi, Asmaa Haj-Khlifa, Youssef Ait Hamdan, Abdelali Ben Maloui, Halima Gamrani, Mohamed Chraa · 2023 · Advances in bioinformatics and biomedical engineering book series
93. Astrocytes in Primary Familial Brain Calcification (PFBC): Emphasis on the Importance of Induced Pluripotent Stem Cell-Derived Human Astrocyte Models
    Ebru Kavakli, Nazli Gul, Onur Can Begentas, Erkan Kiris · 2025 · Advances in experimental medicine and biology
94. In vitro models for human neuroglia
    Bas Lendemeijer, Femke M. S. de Vrij · 2025 · Handbook of clinical neurology
95. Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson’s Disease Pathogenesis and Drug Screening
    Jihong Liu, Wanlin Zhao, Zijuan Zhang, Xilei Ai, Bing Cao, Zhenqiang Zhang, Dongrui Ma · 2025 · Stem Cell Reviews and Reports
96. Astrocyte Secretome Profiling via Biorthogonal Labeling Unveils Novel Factors Relevant to Neurodegenerative Diseases
    Jie Liu, Jing Gao, Lin Guo, Guoming Ma, Mingfeng Guan, Congcong Xia, Jia He, Yufang Yang, Yi Wu, Jun Xu et al. · 2025 · Glia
97. KFERQ-selective protein autophagy in Caenorhabditis elegans depends on LMP-1
    María Gallardo-Campos, Alicia N. Minniti, Juan Hormazábal, Gonzalo Núñez, Carlos F. Lagos, Tomás Pérez‐Acle, Rebeca Aldunate, Iván E. Alfaro · 2025 · PLoS ONE
98. Human pluripotent stem cell models of Friedreich’s ataxia: innovations, considerations, and future perspectives
    Ha Thi Nguyen, Марек Напиерала, Jill S. Napierala · 2026 · Stem Cell Research & Therapy
99. Damage-Derived Reactive Glia from a Parkinson’s Disease Model Are Neurotoxic to Substantia Nigra Dopaminergic Neurons in Naïve Animals
    Agustina Dapueto, Silvia Olivera‐Bravo, Giselle Prunell · 2026 · Neuroglia
100. Mitochondrial DNA Damage in Substantia Nigra Pars Compacta Astrocytes Exacerbates Dopaminergic Neuron Loss in a 6-Hydroxydopamine Mouse Model of Parkinsonism
     Ayala, Daniela A., Hall, Grace M., Das, Debanjana, Tijerina, Eliana, Villagran, Luisa Lopez, Khan, Zaid, Paliwal, Devanshi, Anand, Anu, Rimer, Mendell, Srinivasan, Rahul · 2026 · Cellular and Molecular Neurobiology